TBS-3
/ Acerus
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
February 03, 2021
Effects of high-intensity training on prostate cancer-induced cardiac atrophy.
(PubMed, Am J Transl Res)
- "This study suggests that high-intensity exercise can improve LV function and increase LV mass concurrent with prostate cancer development, versus sedentary counterparts. Given cardiac dysfunction often manifests with conventional anti-cancer treatments, a short-term high-intensity training program, prior to treatment, may improve cardiac function and fatigue resistance in cancer patients."
Journal • Fatigue • Genito-urinary Cancer • Muscular Atrophy • Oncology • Prostate Cancer • Solid Tumor • Targeted Protein Degradation • CTSB • CTSL
January 01, 2021
Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
(PubMed, J Am Coll Surg)
- "While TBS was associated with survival among patients with wtKRAS tumors, CRLM morphology was not predictive of long-term outcomes among patients with mutKRAS CRLM."
Journal • Liver Cancer • Oncology • KRAS
November 18, 2020
Rat alpha glucosidase inhibitor and phytochemicals activities of endophytic actinobacteria from Ficus deltoidea.
(PubMed, Pak J Pharm Sci)
- "TBL 7, TBL 24, TBS 3, TBS 17 and TBR 20 have high activity...Qualitative phytochemical analysis showed that aqueous and n-hexane extracts of TBL 7 contained flavonoids, phenols, alkaloids, triterpenoids, tannins, and saponins. These results showed that endophytic actinobacteria from F. detoidea have the potential to be developed as α-glucosidase inhibitor."
Journal
October 15, 2020
A Retrospective Comparison of Thrombectomy Followed by Stenting and Thrombectomy Alone for the Management of Deep Vein Thrombosis with May-Thurner Syndrome.
(PubMed, J Vasc Surg Venous Lymphat Disord)
- "TBS is effective and feasible for patients with proximal DVT secondary to MTS. Furthermore, compared with TB, additional stenting might be effective in improving the venous clinical results at follow-up observations."
Journal • Retrospective data • Cardiovascular • Hematological Disorders • Thrombosis • Venous Thromboembolism
April 28, 2020
Differences in Cytopathologist Thyroid Nodule Malignancy Rate.
(PubMed, Cytopathology)
- "There was a similar frequency of use of all thyroid Bethesda system (TBS) categories with the exception of TBS 3 (8.0% and 21.2%, p=0.01)...In conclusion, there is an interobserver difference in the evaluation of thyroid nodule. Clinicians should be aware of such differences since they affect the malignancy rate in each TBS category."
Journal • Head and Neck Cancer • Oncology • Solid Tumor • Thyroid Cancer
1 to 5
Of
5
Go to page
1